Alphatec Holdings, Inc. (ATEC) is a publicly traded Healthcare sector company. As of May 21, 2026, ATEC trades at $8.19 with a market cap of $1.24B and a P/E ratio of -7.27. ATEC moved +0.12% today. Year to date, ATEC is -61.13%; over the trailing twelve months it is -36.47%. Its 52-week range spans $4.88 to $23.29. Analyst consensus is strong buy with an average price target of $18.91. Rallies surfaces ATEC's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
What changed in ATEC news today?
Alphatec Holdings Price Target Cut to $14 After Revenue Miss: Needham cut Alphatec Holdings’ price target from $25 to $14, still implying 95.5% upside potential. Q1 results showed break-even EPS against a $0.01 loss estimate and $192.11 million in revenues, which missed forecasts, driving a 29.86% share decline after a 1.2 million-share fund sale.
Alphatec Holdings Price Target Cut to $14 After Revenue Miss: Needham cut Alphatec Holdings’ price target from $25 to $14, still implying 95.5% upside potential. Q1 results showed break-even EPS against a $0.01 loss estimate and $192.11 million in revenues, which missed forecasts, driving a 29.86% share decline after a 1.2 million-share fund sale.
Does Rallies summarize ATEC news?
Yes. Rallies summarizes ATEC news with ticker-specific context, catalysts, source links, and AI-generated market summaries when news is available.
Is ATEC research on Rallies investment advice?
No. Rallies provides research, data, and educational context for ATEC. It does not provide personalized investment advice.
